22118-4 |
Borrelia burgdorferi Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22118-4 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor Ab CSF Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22119-2 |
Borrelia burgdorferi Ab |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22119-2 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor Ab CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
2212-9 |
Dihydropteridine reductase |
CCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Dihydropteridine reductase [Enzymatic activity/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2212-9 |
|
|
|
|
Both |
|
|
|
0 |
DHP Reduct Ser-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; DHP Reduct; DHPR; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
22120-0 |
Borrelia burgdorferi Ab |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi Ab [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22120-0 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor Ab Fld-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; B/F; Bb; BF; bod; Bodies; Body fluid; Body fluid, unsp; Burgdorf; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.73 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22121-8 |
Borrelia burgdorferi Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22121-8 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22122-6 |
Borrelia burgdorferi Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Borrelia burgdorferi Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22122-6 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22123-4 |
Borrelia burgdorferi Ab.IgA |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22123-4 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgA CSF Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22124-2 |
Borrelia burgdorferi Ab.IgA |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgA Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22124-2 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgA Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22125-9 |
Borrelia burgdorferi Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22125-9 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG CSF Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22126-7 |
Borrelia burgdorferi Ab.IgG |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22126-7 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22127-5 |
Borrelia burgdorferi Ab.IgG |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22127-5 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG Fld-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; B/F; Bb; BF; bod; Bodies; Body fluid; Body fluid, unsp; Burgdorf; Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22128-3 |
Borrelia burgdorferi Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22128-3 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22129-1 |
Borrelia burgdorferi Ab.IgG |
PrThr |
Synv fld |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22129-1 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG Snv Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SF; SNV; Syn; Syn fl; Synov; Synovial fluid |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
2213-7 |
Dimethadione |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Dimethadione [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
2213-7 |
|
|
|
|
Both |
|
|
|
0 |
DMO SerPl-mCnc |
|
|
|
Y |
|
DMO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Propazone; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
22130-9 |
Borrelia burgdorferi Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Borrelia burgdorferi IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22130-9 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22131-7 |
Borrelia burgdorferi Ab.IgG+IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22131-7 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgG+IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22132-5 |
Borrelia burgdorferi Ab.IgM |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22132-5 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM CSF Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22133-3 |
Borrelia burgdorferi Ab.IgM |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22133-3 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM CSF-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Cerebral spinal fluid; Cerebrospinal Fl; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22134-1 |
Borrelia burgdorferi Ab.IgM |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22134-1 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM Fld-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; B/F; Bb; BF; bod; Bodies; Body fluid; Body fluid, unsp; Burgdorf; Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
1.0n |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
22135-8 |
Borrelia burgdorferi Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22135-8 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22136-6 |
Borrelia burgdorferi Ab.IgM |
PrThr |
Synv fld |
Pt |
Ord |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22136-6 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM Snv Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Lyme; Lyme disease; Lymes; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SF; SNV; Syn; Syn fl; Synov; Synovial fluid |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22137-4 |
Borrelia burgdorferi Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Borrelia burgdorferi IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22137-4 |
|
|
|
|
Both |
|
|
|
0 |
B burgdor IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22138-2 |
Borrelia hermsii Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Borrelia hermsii IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22138-2 |
|
|
|
|
Both |
|
|
|
0 |
B hermsii IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B hermsii; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Relapsing fever; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22139-0 |
Borrelia hermsii Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Borrelia hermsii IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22139-0 |
|
|
|
|
Both |
|
|
|
0 |
B hermsii IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B hermsii; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Relapsing fever; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2214-5 |
Dinitrobenzene |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dinitrobenzene [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
2214-5 |
|
|
|
|
Both |
|
|
|
0 |
Dinitrobenz Ur-mCnc |
|
|
|
Y |
|
DNB; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |